Skip to search boxSkip to navigationSkip to main content

CMT-3, a chemically modified tetracycline, inhibits pony metastases and delays the development of paraplegia in a rat model of prostate cancer

  • Marie G. Selzer
    ,
  • Baoqian Zhu
    ,
  • Norman L. Block
    ,
  • Bal L. Lokeshwar(corresponding author)
*Corresponding author for this work
  • University of Miami
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 678-682 (5 pages)

Journal (Volume, Issue Number)

Annals of the New York Academy of Sciences (Volume 878)

Publication milestones

  • Published - 1999

Publication status

Published - 1999

ISSN

0077-8923

Publication IDs

  • Scopus: 0032837305
  • PubMed: 10415806

Publication metrics

Metrics

Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
SciVal
FWCI
1.52
SciVal
Author count
4
SciVal
citations
41
SciVal
Paper percentile
82
Scopus
citations

PlumX, opens in new tab

Captures
12
Citation count
40

Funding Details

FunderFunding number
NCI
R29CA061038